KCAS Bio is proud to announce our participation in the 20th Annual Workshops on Recent Issues in Bioanalysis (WRIB), taking place from April 13th to April 17th, 2026, in Dallas, TX. As a leading event for the bioanalytical community, WRIB brings together global experts to share innovative solutions, discuss emerging trends, and tackle the pressing challenges in bioanalysis and related disciplines.
Innovating Bioanalytical Excellence
At KCAS Bio, innovation is at the core of everything we do. Our bioanalytical services are designed to address the complexities of modern therapeutic development, from biologics to advanced therapies. With cutting-edge instrumentation, validated methodologies, and a commitment to scientific excellence, we deliver reliable data to support regulatory submissions and therapeutic advancements.
Shaping the Future of Bioanalysis
WRIB 2026 serves as a critical platform for addressing both scientific and regulatory issues in bioanalysis. KCAS Bio’s expertise spans key areas, including pharmacokinetics, immunogenicity, and cell and gene therapy analytics, ensuring that we remain at the forefront of this ever-evolving field. By participating in discussions and workshops, we aim to not only share our insights but also learn from peers to further refine our services and strategies.
Meet KCAS Bio at WRIB 2026 in Dallas
The annual WRIB meeting is renowned for fostering collaboration among pharmaceutical, biotech, and regulatory professionals. We invite you to connect with KCAS Bio during WRIB 2026 to explore how our bioanalytical expertise can support your project’s success. Whether you’re navigating the complexities of assay development, seeking advanced analytics for cutting-edge therapies, or requiring regulatory-compliant bioanalysis, our team is here to provide tailored solutions. Contact us today to schedule a meeting at the conference.